![](https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg)
Ideaya aims to raise $263M; Immuneel extends Series A with $12M
Plus, news about XyloCor, Pfizer, Evotech, Skyhawk Therapeutics, HepaRegeniX and Vyome:
Ideaya Biosciences’ $263M public offering: The South San Francisco, CA-based biotech
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.